PHR1589
17-醋酸甲羟孕酮
Pharmaceutical Secondary Standard; Certified Reference Material
别名:
17α-乙酰氧基-6α-甲基孕酮, 17α-羟基-6α-甲基-4-孕烯-3,20-二酮 17-乙酸酯, 6α-甲基-17α-羟基孕酮乙酸酯, 6α-甲基-17α-羟孕酮醋酸酯
登录查看公司和协议定价
所有图片(1)
About This Item
经验公式（希尔记法）:
C24H34O4
CAS号:
分子量:
386.52
Beilstein:
2066112
EC 号:
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
NACRES:
NA.24
等级
certified reference material
pharmaceutical secondary standard
质量水平
Agency
traceable to BP 221
traceable to Ph. Eur. M0250000
traceable to USP 1378001
API类
medroxyprogesterone
CofA
current certificate can be downloaded
包装
ampule of 500 mg
技术
HPLC: suitable
gas chromatography (GC): suitable
mp
206-207 °C (lit.)
应用
pharmaceutical (small molecule)
格式
neat
储存温度
2-30°C
SMILES字符串
[H][C@@]12C[C@H](C)C3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@@]4(C)[C@@]2([H])CC[C@]4(OC(C)=O)C(C)=O
InChI
1S/C24H34O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h13-14,18-20H,6-12H2,1-5H3/t14-,18+,19-,20-,22+,23-,24-/m0/s1
InChI key
PSGAAPLEWMOORI-PEINSRQWSA-N
基因信息
human ... PGR(5241)
正在寻找类似产品? 访问 产品对比指南
一般描述
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Medroxyprogesterone acetate is a synthetic progestational drug utilized as a contraceptive. It is also used as a medication for the treatment of hormone-dependent cancers, such as breast cancer.
应用
Medroxyprogesterone Acetate may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical suspensions, bulk drug and tablet formulations by Raman spectroscopy and chromatography techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAC2690 in the slot below. This is an example certificate only and may not be the lot that you receive.
推荐产品
Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.
相关产品
产品编号
说明
价格
警示用语：
Warning
危险声明
危险分类
Aquatic Chronic 4 - Carc. 2
WGK
WGK 3
法规信息
监管及禁止进口产品
Development and validation of a reversed-phase liquid chromatographic method for analysis of estradiol valerate and medroxyprogesterone acetate in a tablet formulation
Segall A, et al.
Journal of Pharmaceutical and Biomedical Analysis, 19(5), 803-808 (1999)
Raman spectroscopic method for the determination of medroxyprogesterone acetate in a pharmaceutical suspension: validation of quantifying abilities, uncertainty assessment and comparison with the high performance liquid chromatography reference method
De Beer TRM, et al.
Analytica Chimica Acta, 589(2), 192-199 (2007)
Simultaneous determination of estradiol valerate and medroxyprogesterone acetate in a tablet formulation by gas chromatography-mass spectrometry
Yilmaz B
Analytical Sciences, 26(3), 391-393 (2010)
A stability-indicating HPLC method for medroxyprogesterone acetate in bulk drug and injection formulation
Burana-osot J, et al.
Journal of Pharmaceutical and Biomedical Analysis, 40(5), 1068-1072 (2006)
Medroxyprogesterone Acetate
USP42-NF37
United States Pharmacopeia/National Formulary, 29(5), 2707-2707 (2013)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门